COMMUNIQUÉS West-GlobeNewswire
-
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
08/09/2026 -
Raw Garden Launches Solventless Live Rosin All-In-One
08/09/2026 -
BrewDog fait son entrée dans le monde du rugby sous couvert d’un partenariat conclu pour cinq ans avec les Leicester Tigers et colore le stade de Welford Road en punk
08/09/2026 -
Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums
08/09/2026 -
IBA – TRANSPARENCY NOTIFICATION
08/09/2026 -
IBA SA – NOTIFICATION TRANSPARENCE
08/09/2026 -
Med Mart Launches MedMartSupply.com, Expanding More Than 30 Years of Healthcare Experience Into Everyday Medical Supplies
08/09/2026 -
Clariane announces the success of its 2032 €500 million senior notes offering and a new €700m syndicated RCF (5 years, same terms) – subject to final settlement of the notes
08/09/2026 -
Clariane annonce le succès de l’offre de 500 M€ d’obligations senior et l’accord de ses partenaires bancaires pour la mise en place d’un nouveau crédit syndiqué RCF (5 ans, mêmes termes) de 700 M€ – soumis au règlement des obligations
08/09/2026 -
Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors
08/09/2026 -
Beacon Behavioral Partners Adds Prime Psychiatry and Invicta Healthcare, Deepening Dallas-Fort Worth Network
08/09/2026 -
Following R3ALM Strategic Acquisition, Vystar Executes Sale of Remaining Vytex Inventory
08/09/2026 -
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
08/09/2026 -
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
08/09/2026 -
Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers
08/09/2026 -
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026 -
Global Genes Partners with Citizen Health to Power RARE-X
08/09/2026 -
Applied Biologics Welcomes New CMS RAPID Pathway and Expanded CMS-FDA Coordination for Innovative Medical Technologies
08/09/2026 -
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
08/09/2026
Pages